11460 Tomahawk Creek Pkwy. Ste. 420 Leawood, KS

Market Updates

Market Update – February 23rd, 2022

Good evening, The market retreated further today for the 4th consecutive trading session, re-testing the intraday lows of last month and marking its lowest close of the year.  The S&P 500 and the Dow Jones Industrial Average (DJIA) dropped -1.84% and -1.38% respectively while...
Read More →

Market Update Webinar – January 27, 2022

Click below to listen to Kavar Capital Partners discuss 2021 year in review, dissecting the volatility in the New Year, understanding the impact of inflation and implications of Fed tightening in 2022 and beyond.  In order to view the market update webinar facilitated through...
Read More →

Investment Research Note – January 13th, 2022

Courtesy of a 4th quarter rally, stocks finished 2021 on a high note as the US stock market once again displayed resiliency throughout the year.  Major benchmarks finished near all-time highs and generally dodged any significant and largescale drawdowns (or volatility scares) while contending...
Read More →

Market Update Call – March 3, 2021 (Audio)

Click below to listen to Kavar Capital Partners discuss 2020 market performance, attribution and perspective, stimulus/legislative implications on the markets/economy, Covid updates – vaccines/transmission/etc. and planning thoughts – items to consider in the new year.  Market Update Call 3.3.2021

Investment Research Note – February 19th, 2021

This week marks one-year since stocks hit their pre-COVID highs.  In the twelve months since those highs, investors experienced a monumental period for the markets that ran the gamut from a crash with the peak of volatility to “face-ripping” rallies to such downright odd...
Read More →

Market Update Call – July 30, 2020 (Audio)

Click below to listen to Kavar Capital Partners discuss the Fiscal/Monetary Response to COVID 19, YTD Asset Class Review & Identification of Opportunities and a Virus Update – stats on testing, hospitalization, fatalities, transmission rates, vaccine/therapeutics. Market Update Call 7.30.20